Genetic Signatures | GSS - 销售收入

股票价格

0.08

每天变化

0.003 4.00%

每月一次

-35.00%

每年

-85.00%

Q1 预测

0.08

金融业

AUD

AUD 49.04M

现金及等价物

AUD 7.47M

AUD 6.26M

AUD 42.96M

AUD 4.78M

AUD 791K

股息收益率

0

AUD -6.34M

AUD -7.11M

EPS每股收益

AUD -0.01

股本和储备

AUD 44.09M

AUD 4.75M

债务利息支出

AUD 18K

AUD 94K

AUD 13.99M

AUD -15.2M

AUD 17.53M

AUD -6.34M

普通股股本

AUD 127.65M

42.7

AUD -2.45M

AUD 11.19M

销售和管理费用

AUD 908K

AUD 9.06M

贸易债权人

AUD 3.63M

应收帐款人

AUD 6.49M

	销售	更改		日
Avita Medical	AUD 17.61M		805K	2025-12
Medical Developments International	AUD 21.57M		12.04M	2025-12
Neuren Pharmaceuticals	AUD 42.24M		28.1M	2025-12
Pacific Edge	NZD 5.94M		4.95M	2025-12
Paradigm Biopharmaceuticals	AUD -8K		441.66K	2025-06
Starpharma Holdings	AUD 10.83M		9.12M	2025-12
Telix Pharmaceuticals	AUD 413.44M		103.71M	2025-12